$0.25
(1.33%)
Add to watchlist
Create an alert
Stocks and Shares ISAZai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Company Information
About this company
Key people
Ying Du
Chairman of the Board, Chief Executive Officer, Co-Founder
Joshua L. Smiley
President, Chief Operating Officer
Yajing Chen
Chief Financial Officer
Rafael G. Amado
President, Head of Global Research and Development
Frazor Titus Edmondson
Company Secretary, Chief Legal Officer
John David Diekman
Lead Independent Director
Richard B. Gaynor
Independent Director
William David Lis
Independent Director
Scott William Morrison
Independent Director
Leon Oliver Moulder
Independent Director
Click to see more
Key facts
- Shares in issue1.11bn
- EPICZLAB
- ISINUS98887Q1040
- LocationChina
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$2.22bn
- Employees1,869
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.